A Study of Clinical Appearances, Histopathological Features, and Demographic Data in Patients with Oral Potentially Malignant Disorders
Background: Oral squamous cell carcinoma is the most common oral cancer. Oral potentially malignant disorders (OPMDs) can be detected before they turn into oral cancer, thus its prevalence and risk factors should be investigated.
Objectives: This research aims to study the prevalence, clinical appearances, histopathological features, and demographic data in patients with OPMDs in Faculty of dentistry, Chiang Mai University during 2017-2020, along with the relationship between dysplasia level and risk factors.
Methods: This was retrospective and analytical study. The following data were collected and analyzed according to patient’s diagnosis: demographic data and behaviors, clinical appearances, and histopathological features.
Results: The mean age was 60.6±13.0 years, dominate by female (70.9%). The prevalence for each disease was as follow: leukoplakia (28.6%), erythroplakia (8.2%), lichen planus (39.7%), oral submucous fibrosis (2.2%), actinic cheilitis (3.1%), discoid lupus erythematosus (13.3%), lichenoid reaction (1.8%), and candidal leukoplakia (3.1%). Most disorders are found at buccal mucosa as white plaque or mixed red and white lesion along with burning sensation. In histopathological aspect, mild dysplasia was frequently found in all disorders except lichenoid reaction which no dysplasia was found. Fifty-nine percent of patients with smoking history were found with dysplasia while only 21% of non-smoking patients were found with dysplasia.
Conclusions: OPMDs are frequently found in elderly patients above 6th decade and mostly found in female patient. Lichen planus was the most common found among OPMDs. In this retrospective study the relationship between smoking habit and dysplasia was found. No malignancy transformation was found during the study period
1. Lapthanasupkul P, Poomsawat S, Punyasingh J. A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population. Quintessence Int. 2007;38(8):448-55.
2. Warnakulasuriya S, Johnson NW, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10): 575-80.
3. Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, Huang I. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009;9(1):1-7.
4. Li L, Psoter WJ, Buxó CJ, Elias A, Cuadrado L, Morse DE. Smoking and drinking in relation to oral potentially malignant disorders in Puerto Rico: a case-control study. BMC Cancer. 2011;11(1):1-8.
5. Villa A, Gohel A. Oral potentially malignant disorders in a large dental population. J Appl Oral Sci. 2014;22(6):473-6.
6. Worakhajit P, Fuangtharnthip P, Khovidhunkit SOP, Chiewwit P, Klongnoi B. The relationship of tobacco, alcohol, and betel quid with the formation of oral potentially malignant disorders: A community-based study from Northeastern Thailand. Int J Environ Res Public Health. 2021;18(16):8738.
7. Shivakumar KM, Raje V, Kadashetti V. Prevalence of oral potentially malignant disorders (OPMD) in adults of Western Maharashtra, India: A cross-sectional study. J Cancer Res Ther. 2022;18(2):239-43.
8. Mohammed F, Fairozekhan AT. Oral Leukoplakia [Internet]. Florida: StatPearls Publishing; 2023 Jan - [updated 2023 Feb 5; cited 2023 Feb 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK442013/
9. Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ. 2001;65(4):322-7.
10. Parlatescu I, Gheorghe C, Coculescu E, Tovaru S. Oral leukoplakia - an update. Maedica (Bucur). 2014;9(1):88-93.
11. Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633-40.
12. Vlad R, Panainte I, Stoica A, Monea M. The prevalence of oral leukoplakia: results from a Romanian Medical Center. Eur Sci J. 2016;12(27):12-7.
13. Reichart PA, Philipsen HP. Oral erythroplakia-a review. Oral Oncol. 2005;41(6):551-61.
14. Holmstrup P. Oral erythroplakia-What is it?. Oral Dis. 2018; 24(1-2):138-43.
15. Warnakulasuriya S. White, red, and mixed lesions of oral mucosa: A clinicopathologic approach to diagnosis. Periodontol 2000. 2019;80(1):89-104.
16. Shi L, Jiang W, Liu W. Retrospective analysis of oral erythroplakia focused on multiple and multifocal malignant behavior. Oral Dis. 2019;25(7):1829-30.
17. Elenbaas A, Enciso R, Al-Eryani K. Oral lichen planus: a review of clinical features, etiologies, and treatments. Dent Rev. 2021; 100007.
18. Maipanich S, Panpradit N, Okuma N. Oral lichen planus in a patient with ectodermal dysplasia and undifferentiated connective tissue disease. M Dent J. 2018;38(3):249-65.
19. Thongprasom K, Youngnak-Piboonratanakit P, Pongsiriwet S, Laothumthut T, Kanjanabud P, Rutchakitprakarn L. A multicenter study of oral lichen planus in Thai patients. J Investig Clin Dent. 2010;1(1):29-36.
20. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42(6):561-8.
21. Parakh MK, Ulaganambi S, Ashifa N, Premkumar R, Jain AL. Oral potentially malignant disorders: clinical diagnosis and current screening aids: a narrative review. Eur J Cancer Prev. 2020;29(1):65-72.
22. Raman N, Manish K, Jain S. Prevalence of oral submucous fibrosis and periodontal health status in patients chewing Gutka from Bihar region. Int J Med Biomed Stud. 2020;4(1):72-9.
23. Wollina U, Verma SB, Ali FM, Patil K. Oral submucous fibrosis: an update. Clin Cosmet Investig Dermatol. 2015;8:193-204.
24. Sangkaew P, Ittichaicharoen J, Iamaroon A, Prapayasatok S, Pongsiriwet S. Oral potentially malignant disorders: clinical manifestations and malignant transformation. CM Dent J. 2019;40(3):23-42.
25. Bharath TS, Kumar NGR, Nagaraja A, Saraswathi TR, Babu GS, Raju PR. Palatal changes of reverse smokers in a rural coastal Andhra population with review of literature. J Oral Maxillofac Pathol. 2015;19(2):182.
26. Irani S. Pre-cancerous lesions in the oral and maxillofacial region: a literature review with special focus on Etiopathogenesis. Iran J Pathol. 2016;11(4):303-22.
27. Waal Ivd. Atlas of oral diseases : a guide for daily practice. Heidelberg: Springer 2016; 178.
28. Nair D, Pruthy R, Pawar U, Chaturvedi P. Oral cancer: premalignant conditions and screening - an update. J Cancer Res Ther. 2012;8(6):57-66.
29. Wood NH, Khammissa R, Meyerov R, Lemmer J, Feller L. Actinic cheilitis: a case report and a review of the literature. Eur J Dent. 2011;5(01):101-6.
30. Ranginwala AM, Chalishazar MM, Panja P, Buddhdev KP, Kale HM. Oral discoid lupus erythematosus: a study of twenty-one cases. J Oral Maxillofac Pathol. 2012;16(3):368-73.
31. Santiago-Casas Y, Vila LM, McGwin Jr G, Cantor RS, Petri M, Ramsey-Goldman R, et al. Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012;64(5):704-12.
32. Mortazavi H, Safi Y, Baharvand M, Jafari S, Anbari F, Rahmani S. oral white lesions: an updated clinical diagnostic decision tree. Dent J (Basel). 2019;7(1):1-24.
33. Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: an overview of more than 20 entities. J Dent Res Dent Clin Dent Prospects. 2014;8(1):6-14.
34. Gronhagen CM, Nyberg F. Cutaneous lupus erythematosus: an update. Indian Dermatol Online J. 2014;5(1):7-13.
35. Silvia L. Oral lesions in lupus erythematosus: Correlation with cutaneous lesions. Eur J Dermatol. 2008;18(4):376-81.
36. Sarode GS, Batra A, Sarode SC, Yerawadekar S, Patil S. Oral cancer-related inherited cancer syndromes: a comprehensive review. J Contemp Dent Pract. 2016;17(6):504-10.
37. Khudhur S, Di Zenzo G, Carrozzo M. Oral lichenoid tissue reactions: diagnosis and classification. Expert Rev Mol Diagn. 2014;14(2):169–84.
38. Sánchez PS, Sebastián JVB, Soriano YJ, Pérez MGS. Drug-induced oral lichenoid reactions: a literature review. J Clin Exp Dent. 2010;2(2):71-5.
39. Ostman PO, Anneroth G, Skoglund A. Amalgam-associated oral lichenoid reactions. clinical and histologic changes after removal of amalgam fillings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(4):459-65.
40. Thornhill MH, Sankar V, Xu XJ, Barrett AW, High AS, Odell EW, et al. The role of histopathological characteristics in distinguishing amalgam-associated oral lichenoid reactions and oral lichen planus. J Oral Pathol Med. 2006;35(4):233-40.
41. Matangkasombut OP. Oral candidiasis part 1: clinical manifestations and etiology. J Dent Assoc Thai. 2003;56(1):52-63
42. Shah N, Ray JG, Kundu S, Sardana D. Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment. J Lab Physicians. 2017;9(2):136‐9.
43. Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med. 2003;14(4):253-67.
44. Darling MR, McCord C, Jackson-Boeters L, Copete M. Markers of potential malignancy in chronic hyperplastic candidiasis. J Investig Clin Dent. 2012;3(3):176‐81.
45. Wu L, Feng J, Shi L, Shen X, Liu W, Zhou Z. Candidal infection in oral leukoplakia: a clinicopathologic study of 396 patients from eastern China. Ann Diagn Pathol. 2013;17(1):37-40.
46. Klongnoi B, Sresumatchai V, Clypuing H, Wisutthajaree A, Pankam J, Srimaneekarn N, et al. Histopathological and risk factor analyses of oral potentially malignant disorders and oral cancer in a proactive screening in northeastern Thailand. BMC Oral Health. 2022;22(1):1-13.
47. Phudphong S. Factors related to oral and dental health care behaviors of the elderly in Muang Sam Sip district, Ubon Ratchathani province. J Health Sci. 2020;4(1):101-19.
48. Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J. 2011;56(3):253-6.
49. Moles MG, Warnakulasuriya S, González-Ruiz I, Rodríguez ÁA, González-Ruiz L, Avila IR, et al. Dysplasia in oral lichen planus: relevance, controversies and challenges. a position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):541-8.
50. Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y. Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies. J Maxillofac Surg. 2017;8(2):89-94.
51. Muse ME, Crane JS. Actinic Cheilitis [Internet]. Florida: StatPearls Publishing; 2022 Sep 22 [updated 2022 Sep 22; cited 2022 Nov 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551553/
52. McDaniel B, Sukumaran S, Koritala T, Tanner LS, 2021. Discoid lupus erythematosus [Internet]. Florida: StatPearls Publishing; 2022 Oct 30 [updated 2022 Oct 30; cited 2022 Nov 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493145/
53. Lu SY. Oral candidosis: pathophysiology and best practice for diagnosis, classification, and successful management. J Fungi (Basel). 2021;7(7):555.